Compared with healthy individuals, T2DM patients show significantly higher SGLT2 expression and activity, glucose reabsorption, and a higher threshold for glucosuria (Rahmoune et al. 2005; Tentolouris et al. 2019). This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.